Rock Springs Capital Management LP Relay Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $788,697 - $1.34 Million	55,699 Added 9.01%	673,966 $10.1 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $220,946 - $579,008	16,600 Added 2.76%	618,267 $10.4 Million
Q1 2022 May 16, 2022	BUY	$20.26 - $32.36 $79,014 - $126,204	3,900 Added 0.65%	601,667 $18 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $3.33 Million - $4.75 Million	128,207 Added 27.3%	597,767 $18.4 Million
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $574,234 - $733,282	19,302 Added 4.29%	469,560 $14.8 Million
Q2 2021 Aug 16, 2021	BUY	$27.5 - $38.19 $5.45 Million - $7.57 Million	198,131 Added 78.58%	450,258 $16.5 Million
Q1 2021 May 17, 2021	SELL	$32.52 - $61.53 $5.2 Million - $9.84 Million	-159,873 Reduced 38.8%	252,127 $8.72 Million
Q4 2020 Feb 16, 2021	SELL	$35.51 - $54.03 $59,443 - $90,446	-1,674 Reduced 0.4%	412,000 $17.1 Million
Q3 2020 Nov 16, 2020	BUY	$32.81 - $45.1 $13.6 Million - $18.7 Million	413,674 New	413,674 $17.6 Million

183

127M

1.7K

18K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $780M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.